A Two-Year-Old Startup Is Worth $3.4B for Shooting Down Drones

On August 10, 2026, Cambridge Aerospace closed a $300 million Series C at a $3.4 billion valuation, led by DFJ Growth with participation from Lux, Accel, Lakestar, Never Lift, Ora Global, and Elad Gil.

The company was founded in 2024. It raised a $200 million Series B at $1.3 billion in April 2026 — a 2.6x valuation increase in four months.

Its products: Skyhammer, a drone interceptor; Starhammer, a missile interceptor slated for market next year; and Looking Glass, a radar system. It holds contracts with the UK Ministry of Defence and is building Europe's largest solid rocket motor facility in Norfolk, England, targeting 2,500 Skyhammer units per month by March 2027.

Every number in that paragraph is downstream of one arithmetic problem that European air defense has not solved.

The cost-exchange problem

A Shahed-class attack drone costs somewhere in the low tens of thousands of dollars. The interceptors NATO militaries have historically fired at aerial threats cost hundreds of thousands to low millions each.

Fire a million-dollar missile at a $30,000 drone and you win the engagement and lose the war of attrition. The attacker can produce hundreds per week. The defender's interceptor stockpile is measured in months of production and years of procurement lead time. Ukraine has been running this experiment continuously since 2022, and the finding is unambiguous: mass beats sophistication when the sophistication costs 30x more per shot.

Cambridge Aerospace exists to invert that ratio. A purpose-built interceptor designed from the start against the drone threat — rather than a repurposed air-defense missile designed against aircraft — can be radically cheaper because it does not need the range, the seeker sophistication, or the warhead of a system built to kill a fighter jet.

That is the product thesis, and it is not novel. Perhaps two dozen companies across Europe, the US, and Israel are pursuing versions of it.

The factory is the moat

What separates this raise from the rest of the counter-drone field is the Norfolk facility, and specifically what it makes: solid rocket motors.

Solid rocket motors are the chronic, unglamorous bottleneck in Western munitions. They require energetic materials handling, specialized casting infrastructure, safety separation distances, and a regulatory approval process measured in years. Europe's shortage of them is the reason interceptor production ramps have consistently slipped across the continent since 2022. You cannot buy your way past it quickly, and you cannot outsource it — energetics are export-controlled almost everywhere.

A 2,500 units per month target by March 2027 is 30,000 units a year from a company that did not exist three years ago. If it hits, Cambridge is not a startup with a clever interceptor; it is a strategic production asset that European governments cannot easily replicate and cannot afford to lose.

That is what a $3.4 billion valuation on a pre-scale defense company is actually pricing. Not the missile. The line.

Why the markup happened in four months

A 2.6x step-up between April and August, with no public product milestone in between, is the kind of move that would look reckless in software. In defense tech right now it is closer to rational.

Three things changed underneath the round.

Demand became visible and non-discretionary. European defense budgets are on multi-year upward commitments, and drone defense is the line item with the clearest, most urgent gap. Procurement officers who spent decades optimizing for capability per unit are now optimizing for units per month.

Sovereignty became a specification. European ministries are actively derisking dependence on US systems and US export licensing. A British company producing British interceptors from a British motor plant is not just competitive on price — it is competitive on a criterion that did not carry weight five years ago.

The comparables re-rated. Anduril, Helsing, and a handful of others have established that defense-tech valuations can carry software-like multiples when the company owns manufacturing rather than just integrating it. Cambridge is being priced into that cohort.

What has to be true

The risks are the ones that have killed defense startups for fifty years, and they are unchanged by valuation.

Production is the hard part. 2,500 units a month means qualified suppliers, trained workforce, consistent energetics quality, and a safety record clean enough to keep the site licensed. Every ambitious munitions ramp in Europe since 2022 has missed its schedule. Cambridge's date is seven months out.

Government revenue is lumpy and political. MoD contracts today are contracts under a government that prioritizes this spending. Programs get restructured, delayed, and cancelled for reasons that have nothing to do with the product working.

A cheap interceptor invites a cheaper attacker. Counter-drone is an adaptation race, not a solved problem. Fiber-optic-guided drones, autonomous terminal guidance, and saturation swarms all exist specifically to defeat the current generation of defenses. Whatever works in 2027 gets countered by 2029, and the company's value depends on iterating faster than the threat.

Peace is a risk factor. It is grim to write and it is true: a meaningful de-escalation in Eastern Europe would compress these multiples hard.

The counter to all of it is that even under a ceasefire, no European government now believes it can maintain thin interceptor stockpiles. The lesson of the past four years was not about one conflict. It was that cheap aerial mass is a permanent feature of warfare, and every state that can be reached by a drone now has a standing requirement to shoot them down affordably.

Cambridge Aerospace is two years old and building a factory for that requirement. The valuation is aggressive. The bet underneath it is not.